CATALOGO DEI PRODOTTI DELLA RICERCA

GAIBANI, Paolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.822
AS - Asia 2.680
EU - Europa 2.306
SA - Sud America 487
Continente sconosciuto - Info sul continente non disponibili 222
AF - Africa 171
OC - Oceania 4
Totale 9.692
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.695
RU - Federazione Russa 1.385
SG - Singapore 1.213
IT - Italia 526
HK - Hong Kong 394
BR - Brasile 375
VN - Vietnam 262
BD - Bangladesh 261
CN - Cina 254
GB - Regno Unito 163
KR - Corea 121
BJ - Benin 59
CA - Canada 52
DE - Germania 51
IN - India 42
NG - Nigeria 42
AR - Argentina 38
MX - Messico 37
NL - Olanda 29
EC - Ecuador 24
FI - Finlandia 23
FR - Francia 19
AT - Austria 18
ID - Indonesia 18
ZA - Sudafrica 18
IQ - Iraq 16
TR - Turchia 16
PL - Polonia 15
VE - Venezuela 15
ES - Italia 14
IE - Irlanda 12
PY - Paraguay 12
TG - Togo 12
SE - Svezia 11
UA - Ucraina 10
UZ - Uzbekistan 10
CL - Cile 9
JP - Giappone 9
PK - Pakistan 9
SA - Arabia Saudita 9
KE - Kenya 8
PH - Filippine 8
MA - Marocco 7
CR - Costa Rica 6
DZ - Algeria 6
JM - Giamaica 6
CO - Colombia 5
HN - Honduras 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
BO - Bolivia 4
DO - Repubblica Dominicana 4
EE - Estonia 4
KZ - Kazakistan 4
TN - Tunisia 4
AU - Australia 3
BY - Bielorussia 3
GT - Guatemala 3
JO - Giordania 3
LB - Libano 3
MY - Malesia 3
PE - Perù 3
AM - Armenia 2
AZ - Azerbaigian 2
BB - Barbados 2
BG - Bulgaria 2
BW - Botswana 2
EG - Egitto 2
HU - Ungheria 2
IL - Israele 2
IR - Iran 2
LT - Lituania 2
NI - Nicaragua 2
NP - Nepal 2
PA - Panama 2
PS - Palestinian Territory 2
RO - Romania 2
RS - Serbia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
ZW - Zimbabwe 2
AF - Afghanistan, Repubblica islamica di 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CH - Svizzera 1
CU - Cuba 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DM - Dominica 1
GA - Gabon 1
GD - Grenada 1
GP - Guadalupe 1
GR - Grecia 1
HR - Croazia 1
HT - Haiti 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LR - Liberia 1
Totale 9.455
Salva come PNG Salva come JPEG
Città #
San Jose 823
Ashburn 715
Singapore 689
Dallas 538
Moscow 453
Hong Kong 393
Council Bluffs 271
Verona 171
The Dalles 140
Ho Chi Minh City 85
Los Angeles 74
London 73
Hanoi 72
New York 65
Buffalo 59
Cotonou 59
Redondo Beach 54
Santa Clara 54
McKinney 53
Milan 42
Rome 40
Abuja 39
São Paulo 38
Beijing 36
Phoenix 29
Annandale 27
Mexico City 24
North Hollywood 24
Brooklyn 19
Montreal 19
Munich 19
Bologna 16
Chandler 16
Cleveland 16
Houston 16
Da Nang 15
Naples 15
Warsaw 15
Chicago 14
Nuremberg 14
Atlanta 13
Lomé 12
Porto Alegre 12
Helsinki 11
Woodbridge 11
Amsterdam 10
Dublin 10
Toronto 10
Turin 10
Biên Hòa 9
Chennai 9
Haiphong 9
Tashkent 9
Vienna 9
Belo Horizonte 8
New Delhi 8
Orem 8
Tokyo 8
Turku 8
Boston 7
Campinas 7
Columbus 7
Guarulhos 7
Salvador 7
San Francisco 7
Birmingham 6
Guayaquil 6
Hải Dương 6
Jacksonville 6
Jakarta 6
Nairobi 6
Quito 6
Rio de Janeiro 6
Santiago 6
Southend 6
Stockholm 6
Baghdad 5
Betim 5
Bắc Ninh 5
Can Tho 5
Caracas 5
Casablanca 5
Catania 5
Cincinnati 5
Dhaka 5
Johannesburg 5
Las Vegas 5
Mumbai 5
North Bergen 5
Padua 5
Palermo 5
Riyadh 5
San José 5
Tampa 5
Taranto 5
Valencia 5
Agrolândia 4
Ambato 4
Asunción 4
Cape Town 4
Totale 5.742
Salva come PNG Salva come JPEG
Nome #
Epidemiology and Genomic Characterization of Trichophyton mentagrophytes over a Period of 4 Years in Northern Italy 318
Microbiological and pharmacological tests on new antibiotic-loaded PMMA-based composites for the treatment of osteomyelitis 163
Blood culture systems: rapid detection-how and why? 142
Ceftolozane-Tazobactam Treatment of Hypervirulent Multidrug Resistant Pseudomonas aeruginosa Infections in Neutropenic Patients 134
Characterization of the genome of a Klebsiella pneumoniae clinical strain carrying a novel KPC-205 variant associated with resistance to ceftazidime/avibactam and cefiderocol 129
Clinical Characteristics and Genomic Analysis of a Trichophyton indotineae Strain Resistant to Terbinafine and Fluconazole Isolated in Italy 128
Performance evaluation of Bruker UMIC® microdilution panel and disc diffusion to determine cefiderocol susceptibility in Enterobacterales, Acinetobacter baumannii, Pseudomonas aeruginosa, Stenotrophomonas maltophilia, Achromobacter xylosoxidans and Burkolderia species 118
Carbapenem resistant bacteria in Intensive Care Unit during COVID-19 pandemic: Multicenter before-after cross sectional study 112
Complete Genome Sequence of a Klebsiella pneumoniae Strain Carrying Novel Variant blaKPC-203, Cross-Resistant to Ceftazidime/Avibactam and Cefiderocol, but Susceptible to Carbapenems, Isolated in Italy, 2023 105
Colistin: Lights and Shadows of an Older Antibiotic 104
A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime-avibactam for treating DTR gram-negative infections in a case series of critically ill patients undergoing continuous veno-venous haemodiafiltration (CVVHDF) 103
Synergistic Activity of Cefiderocol in Combination with Avibactam, Sulbactam or Tazobactam against Carbapenem-Resistant Gram-Negative Bacteria 103
Bloodstream infection caused by KPC-producing Klebsiella pneumoniae resistant to ceftazidime/avibactam: epidemiology and genomic characterization 98
A descriptive case series of pharmacokinetic/pharmacodynamic target attainment and microbiological outcome in critically ill patients with documented severe extensively drug-resistant Acinetobacter baumannii bloodstream infection and/or ventilator-associated pneumonia treated with cefiderocol 96
Clonal Dissemination of Candida auris Clinical Isolates in Northern Italy, 2021 94
A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion meropenem/vaborbactam in the treatment of critically ill patients with documented KPC-producing Klebsiella pneumoniae ventilator-associated pneumonia 93
Case report of Usutu virus infection in an immunocompromised patient in Italy, 2022 92
Infections in liver and lung transplant recipients: a national prospective cohort 92
Clinical consequences of very major errors with semi-automated testing systems for antimicrobial susceptibility of carbapenem-resistant Enterobacterales 90
A novel method to evaluate ceftazidime/avibactam therapy in patients with carbapenemase-producing Enterobactericeae (CPE) bloodstream infections 90
Clinical application of Bruker Biotyper MALDI-TOF/MS system for real-time identification of KPC production in Klebsiella pneumoniae clinical isolates 89
In vitro activity of cefiderocol against European Pseudomonas aeruginosa and Acinetobacter spp., including isolates resistant to meropenem and recent β-lactam/β-lactamase inhibitor combinations 89
Rectal screening of carbapenemase-producing Enterobacteriaceae: a proposed workflow 89
Cefiderocol treatment for carbapenem-resistant Acinetobacter baumannii infection in the ICU during the COVID-19 pandemic: a multicentre cohort study 89
Heterogeneity of West Nile virus genotype 1a in Italy, 2011 88
Colonization by ceftazidime/avibactam-resistant KPC-producing Klebsiella pneumoniae following therapy in critically ill patients 87
Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre study 86
Effect of incremental tazobactam concentrations on the bactericidal activity of piperacillin against ESBL-producing enterobacterales clinical isolates causing bacteraemia 84
Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study) 83
Comparative Usutu and West Nile virus transmission potential by local Culex pipiens mosquitoes in north-western Europe 83
In vitro activity and genomic characterization of KPC-producing Klebsiella pneumoniae clinical blood culture isolates resistant to ceftazidime/avibactam, meropenem/vaborbactam, imipenem/relebactam: an Italian nationwide multicentre observational study (2022-23) 82
A rapid and specific real-time RT-PCR assay to identify Usutu virus in human plasma, serum, and cerebrospinal fluid 82
Pharmacokinetics/pharmacodynamics of cefiderocol administered by continuous infusion in a case series of critically ill patients with carbapenem-resistant Acinetobacter baumannii infections undergoing continuous venovenous haemodiafiltration (CVVHDF) 82
Isolation and genome characterization of a Klebsiella pneumoniae clinical strain carrying blaNDM-5 and blaOXA-48 isolated in Italy 81
Chikungunya: an emerging and spreading arthropod-borne viral disease 81
In vitro activity of cefiderocol against European Enterobacterales, including isolates resistant to meropenem and recentβ-lactam/β-lactamase inhibitor combinations 81
Clinical application of a molecular method based on real time RT-PCR for detection od influenza A(H1N1)v 80
In Vitro Evaluation of Increasing Avibactam Concentrations on Ceftazidime Activity against Ceftazidime/Avibactam-Susceptible and Resistant KPC-Producing Klebsiella pneumoniae Clinical Isolates 80
Genomic characterization of a high pathogenic Escherichia coli causing bacterial meningitis in a newborn in Italy, 2022: E. coli neonatal meningitis 80
A novel IncA plasmid carrying blaVIM-1 in a Kluyvera cryocrescens strain 80
Antiviral activity of interferon-based combination therapy in critically ill patients with COVID-19: Preliminary observations 76
Resistance to sulbactam/durlobactam in carbapenem-resistant Acinetobacter baumannii in treatment-naive setting: in vitro data and genomic insights from Italian bloodstream isolates 76
Carbapenemase-producing Enterobacterales: changing epidemiology in a highly endemic Italian area 76
Microbiological Investigation and Clinical Efficacy of Professional Topical Fluoride Application on Streptococcus mutans and Selemonas sputigena in Orthodontic Patients: A Randomized Controlled Clinical Trial 75
Mosquito, bird and human surveillance of west nile and usutu viruses in Emilia-Romagna region (Italy) in 2010 74
Epidemiology and Genetic Traits of Carbapenemase-Producing Enterobacterales: A Global Threat to Human Health 73
Dynamic evolution of imipenem/relebactam resistance in a KPC-producing Klebsiella pneumoniae from a single patient during ceftazidime/avibactam-based treatments 73
Pharmacokinetic/Pharmacodynamic Analysis of Continuous-Infusion Fosfomycin in Combination with Extended-Infusion Cefiderocol or Continuous-Infusion Ceftazidime-Avibactam in a Case Series of Difficult-to-Treat Resistant Pseudomonas aeruginosa Bloodstream Infections and/or Hospital-Acquired Pneumonia 71
Complete Genome Sequence of a Multidrug-Resistant Klebsiella pneumoniae Strain Carrying blaOXA181and blaKPC-125Carbapenemase 71
In vivo evolution of resistant subpopulations of KPC-producing Klebsiella pneumoniae during ceftazidime/avibactam treatment 71
Genomic epidemiology of Klebsiella pneumoniae: the Italian scenario, and novel insights into the origin and global evolution of resistance to carbapenem antibiotics 70
Humans parasitized by the hard tick Ixodes ricinus are seropositive to Midichloria mitochondrii: is Midichloria a novel pathogen, or just a marker of tick bite? 69
In vivo emergence of ceftazidime/avibactam, cefiderocol and aztreonam/avibactam cross-resistance in a patient with KPC-producing Klebsiella pneumoniae infection after Cefiderocol-based treatment 69
Serodiagnosis of visceral leishmaniasis in northeastern italy: Evaluation of seven serological tests 69
In vivo emergence of cefiderocol and ceftazidime/avibactam cross-resistance in KPC-producing Klebsiella pneumoniae following ceftazidime/avibactam -based therapies 67
Inflammatory cytokine expression is associated with chikungunya virus resolution and symptom severity 66
Diagnostic methods for CHIKV based on serological tools 66
Recent Advances in the Evaluation of Serological Assays for the Diagnosis of SARS-CoV-2 Infection and COVID-19 65
In vivo development of resistance to novel β-lactam/β-lactamase inhibitor combinations in KPC-producing Klebsiella pneumoniae infections: a case series 65
Persistence of anti-chikungunya virus-specific antibodies in a cohort of patients followed from the acute phase of infection after the 2007 outbreak in Italy 64
Complete genome sequence and antimicrobial resistance analysis of ESBL-producing Shigella sonnei carrying small cryptic plasmids isolated in northern Italy 64
Diagnosis of west nile virus human infections: overview and proposal of diagnostic protocols considering the results of external quality assessment studies 63
Comparison of Broth Microdilution, Disk Diffusion and Strip Test Methods for Cefiderocol Antimicrobial Susceptibility Testing on KPC-Producing Klebsiella pneumoniae 63
Toscana virus infections in northern Italy: laboratory and clinical evaluation 63
Epidemiology and In Vitro Activity of Ceftazidime/Avibactam, Meropenem/Vaborbactam and Imipenem/Relebactam against KPC-Producing K. pneumoniae Collected from Bacteremic Patients, 2018 to 2020 63
Treponema Denticola alters cell vitality and induces HO1 and HSP70 expression in porcine Aortic Endothelial cells 63
Rapid increase of carbapenemase-producing Klebsiella pneumoniae strains in a large Italian hospital: surveillance period 1 March - 30 September 2010 62
Usutu virus infection in a patient who underwent orthotropic liver transplantation, Italy, August- September 2009 62
The lower respiratory tract microbiome of critically ill patients with COVID-19 62
Genome characterization of a Klebsiella pneumoniae co-producing OXA-181 and KPC-121 resistant to ceftazidime/avibactam, meropenem/vaborbactam, imipenem/relebactam and cefiderocol isolated from a critically ill patient 61
Draft Genome of Klebsiella pneumoniae Sequence Type 512, a Multidrug-Resistant Strain Isolated during a Recent KPC Outbreak in Italy 61
In vitro activity and resistance mechanisms of novel antimicrobial agents against metallo-β-lactamase producers 61
In vitro activity of imipenem-relebactam against KPC-producing Klebsiella pneumoniae resistant to ceftazidime-avibactam and/or meropenem-vaborbactam 60
Clonal dissemination of Klebsiella pneumoniae resistant to cefiderocol, ceftazidime/avibactam, meropenem/vaborbactam and imipenem/relebactam co-producing KPC and OXA-181 carbapenemase 60
Evaluation of five carbapenemase detection assays for Enterobacteriaceae harbouring bla KPC variants associated with ceftazidime/avibactam resistance 59
Serum bactericidal titres for monitoring antimicrobial therapy: current status and potential role in the management of multidrug-resistant Gram-negative infections 59
Respiratory bacterial co-infections in intensive care unit-hospitalized COVID-19 patients: Conventional culture vs BioFire FilmArray pneumonia Plus panel 58
Whole Genome Sequencing of a Chlamydia trachomatis Strain Responsible for a Case of Rectal Lymphogranuloma Venereum in Italy 58
Human infection with highly pathogenic a(H7N7) avian influenza virus, Italy, 2013 57
Resistance to Ceftazidime/Avibactam, Meropenem/Vaborbactam and Imipenem/Relebactam in Gram-Negative MDR Bacilli: Molecular Mechanisms and Susceptibility Testing 56
Phenotypic and genotypic characterization of Klebsiella pneumoniae strains with reduced susceptibiliy to carbapenems 56
The central region of the msp gene of Treponema denticola has sequence heterogeneity among clinical samples, obtained from patients with periodontitis 55
Do mosquito-associated bacteria of the genus Asaia circulate in humans? 55
In vitro interaction of ceftazidimeâ avibactam in combination with different antimicrobials against KPC-producing Klebsiella pneumoniae clinical isolates 55
Successful Treatment of Bacteremia and Ventilator-Associated Pneumonia Caused by KPC/OXA-48-like Klebsiella pneumoniae Co-Producer with a Continuous Infusion of High-Dose Meropenem Plus Fosfomycin Guided by Real-Time Therapeutic Drug Monitoring 54
Successful containment and infection control of a Carbapenem-resistant Klebsiella pneumoniae outbreak in an Italian hospital 54
Detection of West Nile virus RNA (lineages 1 and 2) in an external quality assessment programme for laboratories screening blood and blood components for West Nile virus by nucleic acid amplification testing 54
Detection of specific antibodies against West Nile and Usutu viruses in healthy blood donors in northern Italy, 2010-2011 54
Successful Treatment of Bloodstream Infection due to a KPC-Producing Klebsiella Pneumoniae Resistant to Imipenem/Relebactam in a Hematological Patient 54
Persistence of anti-west nile virus-specific antibodies among asymptomatic blood donors in Northeastern Italy 54
Severe Escherichia coli infections in critical adult patients: two case reports and genomic analysis 54
Novel CMY-186 variant conferring cross-resistance to cefiderocol and ceftazidime/avibactam in Klebsiella pneumoniae from a critically ill patient during cefiderocol and ceftazidime/avibactam treatment 53
Serological and molecular tools to diagnose visceral leishmaniasis: 2-years' experience of a single center in Northern Italy 53
Evaluation of Phenotypic and Genotypic Approaches for the Detection of Class A and Class B Carbapenemases inEnterobacteriaceae 53
New evidence of cutaneous leishmaniasis in north-eastern Italy 53
False-positive transcription-mediated amplification assay detection of West Nile virus in blood from a patient with viremia caused by an Usutu virus infection 53
Updates on the Activity, Efficacy and Emerging Mechanisms of Resistance to Cefiderocol 53
Imported cases of dengue virus infection: Emilia-Romagna, Italy, 2010 52
The experience of West Nile virus integrated surveillance system in the Emilia-Romagna region: five years of implementation, Italy, 2009 to 2013 52
Outbreak of Citrobacter freundii carrying VIM-1 in an Italian Hospital, identified during the carbapenemases screening actions, June 2012 52
Totale 7.774
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.741
article - articoli 36.473
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 268
Totale 73.482
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223 0 0 0 0 0 0 0 0 0 0 1 2
2022/202338 5 4 3 8 3 8 0 3 2 1 1 0
2023/202417 1 0 3 4 2 4 1 1 0 0 1 0
2024/20251.593 57 23 18 66 27 164 76 60 221 104 230 547
2025/20266.719 457 572 434 846 1.359 316 838 459 464 323 339 312
2026/20271.279 179 284 236 580 0 0 0 0 0 0 0 0
Totale 9.692